Epidemiology of arrhythmogenic ventricular cardiomyopathy in China
© 2023 The Authors. Clinical Cardiology published by Wiley Periodicals LLC..
BACKGROUND: Arrhythmogenic ventricular cardiomyopathy (AVC) is a common cause of ventricular arrhythmias and mortality, but limited data are available from large Asian cohorts. Our aim was to explore the current status of AVC and second, we examined the prevalence of ventricular tachycardia (VT), heart failure (HF) and mortality in patients with AVC in the Chinese population.
HYPOTHESIS: At present, some studies have reported that the incidence of AVC is on the rise, which may be due to the increasing number of diagnostic methods for AVC. However, there is no epidemiological data on AVC in the Chinese population, so we speculate that the incidence of AVC in the Chinese population is increasing.
METHODS AND RESULTS: We studied 15 888 adults from the Beijing Municipal Health Commission Information Center (BMHCIC) registry database in China from January 2010 to December 2020, and calculated the average annual percentage change (AAPC). Second, we determined the incidence of VT, HF and mortality in patients with AVC. Of the 10 318 men and 5570 women who were screened by cardiac magnetic resonance or examined by myocardial biopsy, there were a total of 256 newly diagnosed AVC patients (mean [SD]: 37.54[17.10]; 39.45% female). The incidence of AVC increased from 7.60 (3.12-12.06) in 2010 to 19.62 (11.51-27.75) per 1000 person-years in 2020. Males had higher incidence of AVC than females. The AAPC for the rising incidence of AVC was 8.9 %. Males had similar VT prevalence (70.32% vs. 62.38%, p = 0.19) and mortality (1.94% vs. 1.98%, p = 0.98) but lower HF prevalence (42.58% vs. 60.40%, p = 0.006), when compared to females. Radiofrequency ablation (RFA) was more likely to be performed in males (p = 0.006).
CONCLUSIONS: The rising trend in AVC incidence was evident, with two-fold increase by 2020. Males with AVC had similar VT prevalence and mortality rate, but HF prevalence were lower than females, perhaps impacted by RFA use.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
---|---|
Enthalten in: |
Clinical cardiology - 47(2024), 1 vom: 28. Jan., Seite e24160 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Liu, Si-Tong [VerfasserIn] |
---|
Links: |
---|
Themen: |
Arrhythmogenic ventricular cardiomyopathy |
---|
Anmerkungen: |
Date Completed 26.01.2024 Date Revised 26.01.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/clc.24160 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364071680 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364071680 | ||
003 | DE-627 | ||
005 | 20240126232007.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/clc.24160 |2 doi | |
028 | 5 | 2 | |a pubmed24n1271.xml |
035 | |a (DE-627)NLM364071680 | ||
035 | |a (NLM)37915277 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Liu, Si-Tong |e verfasserin |4 aut | |
245 | 1 | 0 | |a Epidemiology of arrhythmogenic ventricular cardiomyopathy in China |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.01.2024 | ||
500 | |a Date Revised 26.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. Clinical Cardiology published by Wiley Periodicals LLC. | ||
520 | |a BACKGROUND: Arrhythmogenic ventricular cardiomyopathy (AVC) is a common cause of ventricular arrhythmias and mortality, but limited data are available from large Asian cohorts. Our aim was to explore the current status of AVC and second, we examined the prevalence of ventricular tachycardia (VT), heart failure (HF) and mortality in patients with AVC in the Chinese population | ||
520 | |a HYPOTHESIS: At present, some studies have reported that the incidence of AVC is on the rise, which may be due to the increasing number of diagnostic methods for AVC. However, there is no epidemiological data on AVC in the Chinese population, so we speculate that the incidence of AVC in the Chinese population is increasing | ||
520 | |a METHODS AND RESULTS: We studied 15 888 adults from the Beijing Municipal Health Commission Information Center (BMHCIC) registry database in China from January 2010 to December 2020, and calculated the average annual percentage change (AAPC). Second, we determined the incidence of VT, HF and mortality in patients with AVC. Of the 10 318 men and 5570 women who were screened by cardiac magnetic resonance or examined by myocardial biopsy, there were a total of 256 newly diagnosed AVC patients (mean [SD]: 37.54[17.10]; 39.45% female). The incidence of AVC increased from 7.60 (3.12-12.06) in 2010 to 19.62 (11.51-27.75) per 1000 person-years in 2020. Males had higher incidence of AVC than females. The AAPC for the rising incidence of AVC was 8.9 %. Males had similar VT prevalence (70.32% vs. 62.38%, p = 0.19) and mortality (1.94% vs. 1.98%, p = 0.98) but lower HF prevalence (42.58% vs. 60.40%, p = 0.006), when compared to females. Radiofrequency ablation (RFA) was more likely to be performed in males (p = 0.006) | ||
520 | |a CONCLUSIONS: The rising trend in AVC incidence was evident, with two-fold increase by 2020. Males with AVC had similar VT prevalence and mortality rate, but HF prevalence were lower than females, perhaps impacted by RFA use | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Chinese population | |
650 | 4 | |a arrhythmogenic ventricular cardiomyopathy | |
650 | 4 | |a epidemiology | |
700 | 1 | |a Li, Rui |e verfasserin |4 aut | |
700 | 1 | |a Zheng, Jian-Peng |e verfasserin |4 aut | |
700 | 1 | |a Lu, Feng |e verfasserin |4 aut | |
700 | 1 | |a Sun, Hui-Ni |e verfasserin |4 aut | |
700 | 1 | |a Hua, Lin |e verfasserin |4 aut | |
700 | 1 | |a Lip, Gregory Y H |e verfasserin |4 aut | |
700 | 1 | |a Zhong, Peng |e verfasserin |4 aut | |
700 | 1 | |a Bai, Ying |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical cardiology |d 1992 |g 47(2024), 1 vom: 28. Jan., Seite e24160 |w (DE-627)NLM000419834 |x 1932-8737 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2024 |g number:1 |g day:28 |g month:01 |g pages:e24160 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/clc.24160 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 47 |j 2024 |e 1 |b 28 |c 01 |h e24160 |